N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol

C115H120N30O7 — CID 161090379

IUPACN-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol
SMILESC.COc1cc(-c2ccc(-n3cnc(C)c3)c(CO)n2)nnc1N[C@@H](C)c1ccc(C)cc1.Cc1ccc(C(=O)Nc2ccc(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1ccc(CNc2ccc(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1ccc([C@H](C)Nc2cc(C)c(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1cn(-c2ccc(-c3ccc(N[C@@H](C)c4ccccc4)nn3)nc2CO)cn1
InChIInChI=1S/C24H26N6O2.C24H26N6O.C22H20N6O2.2C22H22N6O.CH4/c1-15-5-7-18(8-6-15)17(3)26-24-23(32-4)11-20(28-29-24)19-9-10-22(21(13-31)27-19)30-12-16(2)25-14-30;1-15-5-7-19(8-6-15)18(4)26-23-11-16(2)24(29-28-23)20-9-10-22(21(13-31)27-20)30-12-17(3)25-14-30;1-14-3-5-16(6-4-14)22(30)25-21-10-8-18(26-27-21)17-7-9-20(19(12-29)24-17)28-11-15(2)23-13-28;1-15-3-5-17(6-4-15)11-23-22-10-8-19(26-27-22)18-7-9-21(20(13-29)25-18)28-12-16(2)24-14-28;1-15-12-28(14-23-15)21-10-8-18(25-20(21)13-29)19-9-11-22(27-26-19)24-16(2)17-6-4-3-5-7-17;/h5-12,14,17,31H,13H2,1-4H3,(H,26,29);5-12,14,18,31H,13H2,1-4H3,(H,26,28);3-11,13,29H,12H2,1-2H3,(H,25,27,30);3-10,12,14,29H,11,13H2,1-2H3,(H,23,27);3-12,14,16,29H,13H2,1-2H3,(H,24,27);1H4/t17-;18-;;;16-;/m00..0./s1
InChIKeyUHBZSDZTXHKTCI-NAXRMEPOSA-N
MW2034.43 g/mol
LogP19.20
Rot. Bonds30

About N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol

N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol (PubChem CID 161090379) has the molecular formula C115H120N30O7 and a molecular weight of 2034.43 g/mol. Its IUPAC name is N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol.

Molecular Properties

Compound NameN-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol
PubChem CID161090379
Molecular FormulaC115H120N30O7
Molecular Weight2034.43 g/mol
Exact Mass2033.00
IUPAC NameN-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol
SMILESC.COc1cc(-c2ccc(-n3cnc(C)c3)c(CO)n2)nnc1N[C@@H](C)c1ccc(C)cc1.Cc1ccc(C(=O)Nc2ccc(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1ccc(CNc2ccc(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1ccc([C@H](C)Nc2cc(C)c(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1cn(-c2ccc(-c3ccc(N[C@@H](C)c4ccccc4)nn3)nc2CO)cn1
InChIInChI=1S/C24H26N6O2.C24H26N6O.C22H20N6O2.2C22H22N6O.CH4/c1-15-5-7-18(8-6-15)17(3)26-24-23(32-4)11-20(28-29-24)19-9-10-22(21(13-31)27-19)30-12-16(2)25-14-30;1-15-5-7-19(8-6-15)18(4)26-23-11-16(2)24(29-28-23)20-9-10-22(21(13-31)27-20)30-12-17(3)25-14-30;1-14-3-5-16(6-4-14)22(30)25-21-10-8-18(26-27-21)17-7-9-20(19(12-29)24-17)28-11-15(2)23-13-28;1-15-3-5-17(6-4-15)11-23-22-10-8-19(26-27-22)18-7-9-21(20(13-29)25-18)28-12-16(2)24-14-28;1-15-12-28(14-23-15)21-10-8-18(25-20(21)13-29)19-9-11-22(27-26-19)24-16(2)17-6-4-3-5-7-17;/h5-12,14,17,31H,13H2,1-4H3,(H,26,29);5-12,14,18,31H,13H2,1-4H3,(H,26,28);3-11,13,29H,12H2,1-2H3,(H,25,27,30);3-10,12,14,29H,11,13H2,1-2H3,(H,23,27);3-12,14,16,29H,13H2,1-2H3,(H,24,27);1H4/t17-;18-;;;16-;/m00..0./s1
InChIKeyUHBZSDZTXHKTCI-NAXRMEPOSA-N
XLogP19.20
TPSA470.05 Ų
H-Bond Donors10
H-Bond Acceptors36
Rotatable Bonds30
Heavy Atoms152
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002034.43
LogP ≤ 519.20
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1036

Analyze N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol?
The IUPAC name of N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol (CID 161090379) is N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol.
What is the SMILES notation for N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol?
The canonical SMILES for N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol is C.COc1cc(-c2ccc(-n3cnc(C)c3)c(CO)n2)nnc1N[C@@H](C)c1ccc(C)cc1.Cc1ccc(C(=O)Nc2ccc(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1ccc(CNc2ccc(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1ccc([C@H](C)Nc2cc(C)c(-c3ccc(-n4cnc(C)c4)c(CO)n3)nn2)cc1.Cc1cn(-c2ccc(-c3ccc(N[C@@H](C)c4ccccc4)nn3)nc2CO)cn1.
What is the InChIKey of N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol?
The InChIKey is UHBZSDZTXHKTCI-NAXRMEPOSA-N. The full InChI is InChI=1S/C24H26N6O2.C24H26N6O.C22H20N6O2.2C22H22N6O.CH4/c1-15-5-7-18(8-6-15)17(3)26-24-23(32-4)11-20(28-29-24)19-9-10-22(21(13-31)27-19)30-12-16(2)25-14-30;1-15-5-7-19(8-6-15)18(4)26-23-11-16(2)24(29-28-23)20-9-10-22(21(13-31)27-20)30-12-17(3)25-14-30;1-14-3-5-16(6-4-14)22(30)25-21-10-8-18(26-27-21)17-7-9-20(19(12-29)24-17)28-11-15(2)23-13-28;1-15-3-5-17(6-4-15)11-23-22-10-8-19(26-27-22)18-7-9-21(20(13-29)25-18)28-12-16(2)24-14-28;1-15-12-28(14-23-15)21-10-8-18(25-20(21)13-29)19-9-11-22(27-26-19)24-16(2)17-6-4-3-5-7-17;/h5-12,14,17,31H,13H2,1-4H3,(H,26,29);5-12,14,18,31H,13H2,1-4H3,(H,26,28);3-11,13,29H,12H2,1-2H3,(H,25,27,30);3-10,12,14,29H,11,13H2,1-2H3,(H,23,27);3-12,14,16,29H,13H2,1-2H3,(H,24,27);1H4/t17-;18-;;;16-;/m00..0./s1.
What are the key properties of N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol?
N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol has a molecular weight of 2034.43 g/mol, XLogP of 19.20, 30 rotatable bonds, 10 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]-4-methylbenzamide;methane;[6-[5-methoxy-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[4-methyl-6-[[(1S)-1-(4-methylphenyl)ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[(4-methylphenyl)methylamino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[6-[[(1S)-1-phenylethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol is sourced from PubChem (CID 161090379), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).